SITOKINE

We use genetic technology to identify patients who will benefit from therapeutics directed against IL-1β or activators of IL-1β, such as Lp(a)... Sitokine uses genetic technology to identify patients who will benefit from terapies against cardiovascular diseases, lung cancer and heart failure

Also known as: Sitokine Ltd.